Document:

<PAGE>   1
                                                                   EXHIBIT 10.1

                         TERMINATION OF CREDIT AGREEMENT

         THIS AGREEMENT (this "Agreement") is made and entered into on this
29th day of December, 2000, and made effective as of the 1st day of October,
2000, by and between:

         AMEDISYS, INC. ("Amedisys"), a corporation organized and existing under
         the laws of the State of Delaware, whose address for purposes of this
         Agreement is 11100 Mead Road, Suite 300, Baton Rouge, LA 70816,
         appearing and acting herein by and through its [duly authorized
         officer**]; and

         HCA - THE HEALTHCARE COMPANY ("HCA"), formerly known as Columbia/HCA
         Healthcare Corporation, a corporation organized and existing under the
         laws of the State of Delaware, whose address for purposes of this
         Agreement is One Park Plaza, Nashville, Tennessee 37203, appearing and
         acting herein by and through its undersigned duly authorized
         representative.

                                    RECITALS

         WHEREAS, Amedisys and HCA are parties to that certain Asset Purchase
Agreement dated November 2, 1998 (the "Asset Purchase Agreement"), pursuant to
which Amedisys purchased certain assets of certain affiliates of HCA;

         WHEREAS, Amedisys and HCA are parties to that certain Credit Agreement,
a copy of which is attached hereto as Exhibit "A," dated November 16, 1998 (the
"Credit Agreement"), pursuant to which HCA agreed to accept a promissory note as
payment of a portion of the purchase price under the Asset Purchase Agreement;

         WHEREAS, pursuant to that certain promissory note, a copy of which is
attached hereto as Exhibit "B," dated December 1, 1998 (the "Note"), Amedisys
promised to pay to the order of HCA the principal sum of Fourteen Million Five
Thousand Nine Hundred Eighty Three and 27/100 Dollars, plus interest, on the
dates, at the rates per annum, and in the amounts provided in the Credit
Agreement;

         WHEREAS, Amedisys and HCA are parties to that certain Loan Modification
Agreement, a copy of which is attached hereto as Exhibit "C," dated September
30, 1999 (the "Loan Modification Agreement"), pursuant to which Amedisys agreed
to make to HCA certain payments that were misdirected to Amedisys, and HCA
agreed to amend certain provisions of the Credit Agreement; and

         WHEREAS, HCA is willing to terminate the Credit Agreement, and Loan
Modification Agreement, and to relieve Amedisys' obligations under the Note in
exchange for a cash payment from Amedisys and the issuance of warrants to
purchase Amedisys common stock, as set forth in that certain Master Warrant
Agreement entered into by Amedisys and HCA, a copy of which is attached hereto
as Exhibit "D," dated December 29th, 2000 ("Master Warrant Agreement").

         NOW, THEREFORE, for and in consideration of the premises and agreements
contained herein and other good and valuable consideration, the receipt and
adequacy of which are hereby forever acknowledged and confessed, the parties
agree as follows:

1.       Incorporation of Recitals. The recitals stated above shall be
         incorporated herein as if fully stated.

** As corrected by hand. Original text read "Chief Executive Officer".
<PAGE>   2

2.       Defined Terms. Unless otherwise defined herein, all terms used herein
         that are defined in the Credit Agreement shall have the same meaning
         herein as therein defined.

3.       Termination of Agreements. The parties agree that as of the effective
         date hereof, and subject to the satisfaction of the mutual obligations
         of the parties contained herein, the Credit Agreement and the Loan
         Modification Agreement shall be terminated, and the obligations of the
         parties thereunder shall immediately cease, provided however, that the
         complete and general release of HCA and its affiliates under Section
         2.3 of the Loan Modification Agreement by Amedisys shall remain in full
         force and effect.

4.       Consideration to HCA. In consideration of HCA entering into this
         Agreement and in full satisfaction of Amedisys' obligations under the
         Credit Agreement, Loan Modification Agreement and the Note:

         a.       Cash Payment. Amedisys shall pay to HCA Nine Million and
                  no/100 ($9,000,000.00) Dollars, in immediately available funds
                  to an account designated by HCA upon execution of this
                  Agreement; and

         b.       Master Warrant Agreement. Amedisys and HCA shall enter into
                  the Master Warrant Agreement pursuant to which HCA shall be
                  issued warrants to purchase up to 200,000 shares of Amedisys,
                  Inc. common stock, subject to the terms and conditions therein
                  set forth.

5.       Consideration to Amedisys. In consideration of Amedisys entering into
         this Agreement and in full satisfaction of HCA's obligations under the
         Credit Agreement, Loan Modification Agreement and the Note, HCA shall
         cancel, as of the effective date hereof, the Note, and Amedisys shall
         have no further obligations whatsoever, including, without limitation,
         any obligation of payment of principal debt or interest, whether or not
         accrued, thereunder. HCA does hereby warrant that it has not sold,
         assigned, transferred, pledged, hypothecated or otherwise encumbered
         the Note, and that HCA shall indemnify and hold Amedisys harmless for
         any such sale, assignment, transfer, pledge, hypothecation or other
         encumbrance of the Note, and for any presentation by a third party to
         Amedisys for payment pursuant to the Note related to any such sale,
         assignment, transfer, pledge, hypothecation or other encumbrance.

6.       Release of Collateral. HCA will immediately take whatever steps
         necessary to release in full any liens or encumbrances held in its
         favor regarding the Collateral, including the filing of UCC-3
         statements or the filing of other documents necessary to effectuate
         said release.

7.       Delivery of Stock Certificates. HCA acknowledges that certain stock
         certificates representing stock holding of Amedisys were pledged and
         delivered to HCA in connection with the Credit Agreement and Loan
         Modification Agreement. HCA agrees to deliver possession of such
         certificates to Amedisys at the time of execution of this Agreement.

8.       Complete and General Release. In consideration of the terms and
         conditions set forth

                                                                          Page 2

                             TERMINATION AGREEMENT

<PAGE>   3

         herein, effective as of the date hereof, the parties hereto agree as
         follows:

         a.       Amedisys hereby presently, generally, fully, finally, and
                  forever, releases, acquits, and discharges HCA and its
                  affiliates, past and present, from any and all theories of
                  recovery of whatsoever nature, whether known or now unknown,
                  or recognized by the law of any jurisdiction, including, but
                  no limited to, actions, causes of action, demands,
                  liabilities, suits and judgments, whether arising in equity or
                  under the common law or any contract or any statute, and from
                  any and all elements of relief or recovery of whatsoever
                  nature, whether known or now unknown, recognized by the law of
                  any jurisdiction, including, but not limited to, actual
                  damages of every description, such as economic loss, any other
                  item of loss or injury, statutory or any other type of damages
                  whatsoever, attorney's fees, prejudgment or post judgment or
                  other interest, equitable relief, and lost income, directly or
                  indirectly arising from or in connection with the Asset
                  Purchase Agreement, the Credit Agreement and the Loan
                  Modification Agreement and the transactions and agreements
                  contemplated therein or related thereto, including, but not
                  limited to, claims arising from representations and warranties
                  in the Asset Purchase Agreement, and the loaning of funds
                  under the Credit Agreement, as amended by the Loan
                  Modification Agreement. Notwithstanding the foregoing, this
                  release does not apply to the obligations of HCA under this
                  Agreement or to any action, cause of action, demand,
                  liability, suit or judgment brought by a third party against
                  Amedisys that is based in whole or in part upon the acts or
                  omissions of HCA or its affiliates.

         b.       HCA hereby presently, generally, fully, finally, and forever,
                  releases, acquits and discharges Amedisys and its affiliates,
                  past and present, from any and all theories of recovery of
                  whatsoever nature, whether known or now unknown, or recognized
                  by the law of any jurisdiction, including, but not limited to,
                  actions, causes of action, demands, liabilities, suits, and
                  judgments, whether arising in equity or under the common law
                  or any contract or any statute, and from any and all elements
                  of relief or recovery of whatsoever nature, whether known or
                  now unknown, recognized by the law of any jurisdiction,
                  including, but not limited to, actual damages of every
                  description, such as economic loss, any other item of loss or
                  injury, statutory or any other type of damages whatsoever,
                  attorney's fees, prejudgment or post judgment or other
                  interest, equitable relief, and lost income, directly or
                  indirectly arising from or in connection with the Asset
                  Purchase Agreement and the transactions and agreements
                  contemplated therein or related thereto, including, but not
                  limited to, claims arising from representations and warranties
                  in the Asset Purchase Agreement and claims related to the
                  payment of the loan under the Credit Agreement, as amended by
                  the Loan Modification Agreement. Notwithstanding the
                  foregoing, this release does not apply to any action, cause of
                  action, demand, liability, suit or judgment brought by a third
                  party against HCA that is based in whole or in part upon the
                  acts or omissions of Amedisys or its affiliates, does not
                  apply to the obligations of Amedisys under the terms of this
                  Agreement or the Master Warrant Agreement and does not apply
                  to the obligation of Amedisys to forward all Excluded Assets
                  (as defined in the Asset Purchase Agreement) to HCA, such
                  Excluded Assets include all misdirected Medicare payments.

                                                                         Page 3

                             TERMINATION AGREEMENT

<PAGE>   4

9.       Authority of HCA. HCA has the right, power, legal capacity and
         authority to enter into and perform HCA's obligations under this
         Agreement and, no approval or consent of any person or entity other
         than HCA is necessary in connection with the execution, delivery, or
         performance of this Agreement by HCA. This Agreement constitutes a
         legal and binding obligation of HCA, and is valid and enforceable
         against HCA in accordance with its terms.

10.      Authority of Amedisys. Amedisys has the right, power, legal capacity
         and authority to enter into and perform Amedisys' obligations under
         this Agreement and, no approval or consent of any person or entity
         other than Amedisys is necessary in connection with the execution,
         delivery, or performance of this Agreement by Amedisys. This Agreement
         constitutes a legal and binding obligation of Amedisys, and is valid
         and enforceable against Amedisys in accordance with its terms.

11.      Miscellaneous.

         a.       Counterparts. This Agreement may be executed in multiple
                  counterparts, each of which shall be deemed an original
                  document and all of which shall constitute one instrument.

         b.       Successors and Assigns. This Agreement shall be binding upon
                  and inure to the benefit of the parties hereto and their
                  respective successors and assigns.

         c.       Governing Law. This Agreement shall be governed by and
                  construed in accordance with the laws of the State of
                  Delaware.

         d.       Notices. All notices and other communications provided for
                  herein shall be given or made in writing by facsimile,
                  courier, or U.S. Mail and faxed, mailed or delivered to the
                  intended recipient at the address stated above.

         e.       Null and Void. This Agreement shall be null and void if HCA
                  does not receive the funds described in Section 4a. hereof by
                  5:00 p.m. CST on December 29, 2000, unless other provisions
                  for the delivery of said funds are expressly agreed to by HCA.

         f.       Entire Agreement. This Agreement constitutes the entire
                  agreement and understanding between the parties relating to
                  the subject matter hereof and supersede all prior agreements
                  and understanding, both written and oral, among the parties,
                  or any of them, with respect to the subject matter hereof.

         IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed, as of the day and year first above written and effective as of
the 1st day of October, 2000.

HCA - THE HEALTHCARE COMPANY                       AMEDISYS, INC.

By:       /s/ GREGG GERKEN                       By:    /s/ JOHN JOFFRION
   ----------------------------------           -------------------------------
                                                John Joffrion, Sr. VP - Finance
Name:         Gregg Gerken
     --------------------------------

Title:        Vice President
      -------------------------------

                                                                         Page 4

                             TERMINATION AGREEMENT<PAGE>   1
                                                                   EXHIBIT 10.2

                            COGNOVIT PROMISSORY NOTE

                                                                 City of Dublin
                                                                  State of Ohio
                                                              December 28, 2000

1. PROMISE TO PAY. For value received, AMEDISYS, INC., a Delaware corporation,
(the "Parent") and those subsidiaries of the Parent listed on Schedule 1
attached hereto (the "Affiliates") (the "Parent" and the "Affiliates" shall be
referred to hereinafter collectively as the "BORROWER"), jointly and severally
promise to pay to NPF CAPITAL, INC., an Ohio corporation (hereinafter the
"LENDER"), or order, the principal sum not to exceed ELEVEN MILLION SEVEN
HUNDRED TWENTY-FIVE THOUSAND AND 00/100 DOLLARS ($11,725,000) together with
interest at the rate set forth below on the unpaid interest and principal
balance from the date hereof, with such balance due and payable in monthly
installments pursuant to the terms and conditions hereof. This Note (the "Note")
shall be subject in all respects to the terms of the Loan and Security Agreement
dated as of even date herewith (the "Loan Agreement"), whereby the BORROWER has
granted to the LENDER a perfected security interest in the BORROWER'S right,
title and interest in, to and under that certain Collateral more specifically
defined in the Loan Agreement. Capitalized terms not defined herein shall have
the meanings as defined in the Loan Agreement.

2. INITIAL LOAN AMOUNT. Subject to Section 12 herein, the LENDER agrees to lend
to the BORROWER an amount not to exceed Nine Million and 00/100 Dollars
($9,000,000) (the "Initial Loan Amount"). The LENDER shall pay the Initial Loan
Amount directly to HCA, the Healthcare Company fka Columbia HCA Healthcare Corp.
("Columbia") on behalf of the BORROWER to satisfy the BORROWER'S obligation to
Columbia under (i) that certain Asset Purchase Agreement dated as of November 2,
1998; (ii) that certain Credit Agreement dated as of November 16, 1998; (iii)
that certain Promissory Note dated as of December 1, 1998; and (iv) that certain
Loan Modification Agreement dated as of September 30, 1999 (collectively the
"Purchase Agreement") by and between Columbia and the BORROWER whereby the
BORROWER purchased from Columbia certain assets pursuant to the terms therein.

3. SUPPLEMENTAL LOAN AMOUNT. Subject to Section 12 herein, the LENDER agrees to
lend to the BORROWER an amount not to exceed Two Million and 00/100 Dollars
($2,000,000) or such lesser portion thereof as may have been disbursed from time
to time by the LENDER to, or for the benefit of the BORROWER, and remaining
unpaid pursuant to the books and records of the LENDER or its affiliates,
together with interest on the unpaid balance of principal advanced from the
date(s) of disbursement until paid in full as set forth below (the "Supplemental
Loan Amount"). The Supplemental Loan Amount shall be used by the BORROWER solely
for the acquisition of businesses, companies and/or their assets. The initial
disbursement of the Supplemental Loan Amount shall be made by the LENDER to the
BORROWER only after the LENDER receives (i) satisfactory verification of the
value of the Collateral pledged under the Loan Agreement and (ii) the
comprehensive business valuation from the BORROWER. Subsequent requests for
disbursements related to the Supplemental Loan Amount shall be made by the
BORROWER to the LENDER five (5) business days prior to

<PAGE>   2

the disbursement. In no event shall disbursements be made if an event of default
exists under any agreement of any nature whatsoever, whether currently existing
or hereafter arising, between the BORROWER and/or any of its affiliates and the
LENDER and/or any of its affiliates.

4. TERM. The term of this Note shall be three (3) years for the Initial Loan
Amount (the "Initial Loan Amount Term") and three (3) years from the initial
disbursement of the Supplemental Loan Amount (the "Supplemental Loan Amount
Term"). The Initial Loan Amount Term and the Supplemental Loan Amount Term may
be referred to herein collectively as the "Term."

5. INTEREST. The interest rate shall be THIRTEEN AND NINETY-FIVE ONE HUNDREDTHS
PERCENT (13.95%) per annum ("Interest"). In the event that (i) the LENDER is in
receipt of complete financial statements for the BORROWER for the periods
through the first quarter of 2001; (ii) there exits no event of default under
any agreement of any nature whatsoever, whether currently existing or hereafter
arising, between the BORROWER, and/or any of its affiliates, and the LENDER,
and/or any of its affiliates; (iii) the BORROWER has sold its interest in
Hammond Surgical Care Center, L.C. dba St. Luke's SurgiCenter; and (iv) the
BORROWER has generated consecutive quarterly net profits as reported in its
required SEC filings for the fourth quarter of 2000 and the first quarter of
2001, the LENDER will re-evaluate the Interest on this Note on or before May 31,
2001. At that time the LENDER may adjust the Interest to be the Prime Rate
("Prime Rate" shall mean the interest rate identified as Bank One, N.A.'s prime
lending rate as published from time to time in The Wall Street Journal) plus
three and one half percent (3.5%). Interest on this Note shall be computed on
the basis of a 360-day year and actual days elapsed. Interest only payments
shall be made with respect to the Initial Loan Amount for six months pursuant to
Section 7 herein. Interest and principal on this Note related to the Initial
Loan Amount shall be amortized over a thirty (30) month period, with such thirty
month amortization period being the final thirty months of the Initial Loan
Amount Term. Interest and principal on the Supplemental Loan Amount shall be
amortized over the Supplemental Loan Amount Term.

6. VALUATION OF ASSETS. The BORROWER and the LENDER agree that Valuation
Counselors ("Valuation Counselors") will perform an appraisal of the BORROWER'S
assets (the "Appraisal"). The Appraisal shall consist of (i) a valuation of the
fixed assets (the "Fixed Asset Appraisal") and (ii) a valuation of the
enterprise value (the "Enterprise Value Appraisal"). The advance rate by the
LENDER to the BORROWER shall be an amount equal to the sum of (i) the product of
(a) 80% multiplied by (b) the Fixed Asset Appraisal plus (ii) the product of (a)
50% multiplied by (b) the Enterprise Value Appraisal (the "Targeted Advance
Rate"). In the event that (i) the Appraisal is received after the Initial Loan
Amount is made by the LENDER to the BORROWER and (ii) the Targeted Advance Rate
is for an amount that is less than the Initial Loan Amount, the BORROWER shall
pay an adjusted rate of Interest equal to Sixteen and Ninety-Five One Hundredths
Percent (16.95%) (the "Adjusted Rate") on the amount equal to (i) the Initial
Loan Amount minus (ii) the Targeted Advance Rate. In the event that the Initial
Loan Amount exceeds the Targeted Advance Rate by an amount that is less than or
equal to Two Million Dollars ($2,000,000), the Adjusted Rate shall be charged on
the entire difference between the Initial Loan Amount and the Targeted Advance
Rate. In the event that the Initial Loan Amount exceeds the Targeted Advance
Rate by an amount that is greater than Two Million Dollars ($2,000,000), the

<PAGE>   3

Adjusted Rate shall be charged on that portion of the difference between the
Initial Loan Amount and the Targeted Advance Rate which is equal to Two Million
Dollars ($2,000,000).

7. INITIAL LOAN AMOUNT INSTALLMENTS. Interest only payments shall be payable in
equal amounts on the last day of each month for the first six months of the
Initial Loan Amount Term commencing January 31, 2001 and continuing thereafter
until June 30, 2001. Principal and interest payments shall be payable in equal
amounts of $386,781.36 for the final thirty months of the Initial Loan Amount
Term commencing July 31, 2001 and continuing thereafter until such time as all
amounts due hereunder have been paid in full.

8. SUPPLEMENTAL LOAN AMOUNT INSTALLMENTS. Principal and interest payments shall
be payable monthly in equal amounts that will be based on the actual amount of
outstanding disbursements. Such principal and interest payments shall be made
during the Supplemental Loan Amount Term with all amounts due hereunder being
paid in full by the last day of the Supplemental Loan Amount Term.

9. PROCEEDS OF SALE. In the event that the Amedisys Surgery Centers, L.C. sells
its interest in Hammond Surgical Care Center, L.C. dba St. Luke's SurgiCenter,
all net cash proceeds (i.e., the gross cash proceeds less all legal fees,
accounting fees, appraisal costs, and the like) shall be paid by the BORROWER to
the LENDER to reduce the outstanding principal balance hereunder.

10. PAYMENT. The BORROWER shall pay the LENDER, in lawful money of the United
States of America, at 6125 Memorial Drive, Dublin, Ohio 43017, Attention: Lance
K. Poulsen or at such other place as the LENDER may designate in writing.

11. SECURITY FOR PAYMENTS. All credits, deposits, account, securities or moneys
of any signer, endorser or guarantor hereof and all other property or rights
belonging to or in which the BORROWER, any signer, endorser or guarantor hereof
has any interest, now or hereafter pledged or hypothecated to the LENDER or in
the possession or control of the LENDER (the Collateral) shall be held by the
LENDER as security for the payment of this Note, and of every other liability
now or hereafter existing of the BORROWER, absolute or contingent, due or to
become due, and in whatsoever manner acquired by or accruing to the LENDER
("Obligations"). The LENDER shall have the right to setoff any such Collateral
at any time without prior notice the BORROWER.

12. FEES TO CLOSE. Fees to close in the amount of Seven Hundred Twenty-Five
Thousand and 00/100 Dollars ($725,000) in the aggregate (the "Fees) shall be due
and owing by the BORROWER to the LENDER on the date hereof. The Fees shall
consist of a debt restructuring fee of $600,000 and a commitment fee of
$125,000. The BORROWER shall pay the Fees to the LENDER pursuant to Section 7
above.

13. CONDITIONS PRECEDENT. The BORROWER shall provide all items that are
outstanding and owed to the LENDER by the BORROWER pursuant to any other
agreement between the BORROWER and/or any of its affiliates and the LENDER
and/or any of its

<PAGE>   4

affiliates, including but not limited to, the release of the
liens referenced on Schedule 2 attached hereto and the delivery of the legal
opinions referenced on Schedule 2 attached hereto in connection with those
certain Sale and Subservicing Agreements dated as of December 10, 1998
(collectively the "Sale Agreement") by and between the Seller, NPF VI, Inc., an
Ohio corporation, and National Premier Financial Enterprises, Inc., an Ohio
corporation. The Seller shall execute amendments to the Sale Agreement whereby
the Termination Date thereunder shall be amended to be a date no earlier than
the date on which all amounts due hereunder are paid in full.

14. TERMINATION OF SALE AGREEMENT. In the event that any Sale Agreement is
terminated, all amounts due hereunder immediately shall become due and payable
and shall be paid on the date of such termination of the Sale Agreement unless
otherwise agreed to in writing by the LENDER.

15. PURPOSE. The BORROWER acknowledges that this Note evidences a loan made
primarily for business or commercial purposes and not primarily for personal,
family or household purposes.

16. PREPAYMENT. The BORROWER may prepay the interest and principal balance
outstanding in whole or in part at any time and without penalty. Any partial
prepayment shall be applied firstly in reduction of interest outstanding, if
any, and secondly in reduction of the principal balance of this Note. Any
prepayment that is applied to outstanding principal will first be applied toward
that portion of the principal carrying the then highest interest rate of all of
the outstanding principal balances. At the time of any prepayment, the BORROWER
has the option of requesting that the Term of this Note be shortened or that the
outstanding balance be re-amortized over the months remaining in the Term so
that the monthly payment due by the BORROWER is reduced.

17. LATE CHARGE. The LENDER shall have the right to charge interest on the
amount of any payment not paid as provided in the Note at the rate of fifteen
percent (15%) or at the same rate as applicable to the principal sum, whichever
is higher. This late charge will be assessed on each payment not received within
five (5) calendar days of its due date, including all regular installments.

18. ACKNOWLEDGMENT. The BORROWER acknowledges (i) that the BORROWER has entered
into the Loan Agreement, whereby the BORROWER has granted to the LENDER a
perfected security interest in the BORROWER'S right, title and interest in, to
and under that certain Collateral more specifically defined in the Loan
Agreement and (ii) that the Parent, Amedisys Specialized Medical Services, Inc.,
Amedisys Surgery Centers, L.C. and Amedisys Alternate-Site Infusion Therapy
Services, Inc. (individually and collectively the "Pledgor") have entered into
that certain Pledge Agreement dated as of even date herewith memorializing the
pledge of such stock by the Pledgor. The BORROWER further acknowledges that the
Loan Agreement and the Pledge Agreement contain the following due on sale
provision:

         LENDER, may, at its option, declare immediately due and payable all
         sums under the Note and may, at its option, enforce its rights under
         the Pledge Agreement and the Loan

<PAGE>   5

         Agreement upon the sale or transfer, without the LENDER'S prior written
         consent, of all or any part of the Collateral or any interest in the
         Collateral. A "sale or transfer" means the conveyance of any right,
         title or interest therein; whether legal, beneficial or equitable;
         whether voluntary, involuntary or by operation of law; whether by
         outright sale, installment sale contract, assignment, or transfer of
         any beneficial interest therein, or by any other method of conveyance
         of property interest. Consent to one such transaction shall not be
         deemed to be a waiver of the right to require such consent to future or
         successive transactions.

19.      DEFAULT.

         (a) The following shall constitute an Event of Default ("Event of
         Default") hereunder:

                  (i) Failure by the BORROWER in the payment when due of the
                  interest and/or principal hereunder.

                  (ii) Any default in the performance of any Obligation to the
                  LENDER by the BORROWER, any endorser or other guarantor
                  hereunder or under the Loan Agreement, and/or the Pledge
                  Agreement, including, but not necessarily limited to, breach
                  of any covenant, Obligation, agreement, representation or
                  warranty contained herein, in the Loan Agreement and/or Pledge
                  Agreement.

                  (iii) Any default by the BORROWER to perform or observe any
                  Obligation, covenant, agreement, representation or warranty
                  contained herein that is not cured within ten (10) days
                  following receipt of written notice thereof.

                  (iv) Dissolution or insolvency of, appointment of a receiver
                  of any of the property of, assignment for the benefit of
                  creditors by, commencement of any proceedings under any
                  bankruptcy or insolvency, including but not limited to the
                  filing of a Chapter 7 or Chapter 11 petition under the
                  Bankruptcy Code laws, by or against the BORROWER, any endorser
                  or other guarantor thereof or attachment, garnishment or
                  creation of a lien against or security interest in any of the
                  Collateral pledged by the BORROWER under the Loan Agreementor
                  in any of the Collateral pledged by the BORROWER under the
                  Pledge Agreement, except as in existence as of the date of
                  this Note.

                  (v) The material default of the BORROWER and/or any of its
                  affiliates under any agreements and/or instruments with the
                  LENDER and/or any of its affiliates.

                  (vi) The failure of the BORROWER to furnish satisfactory
                  Collateral or additional Collateral, as the case may be, as
                  the LENDER, in its sole discretion, may require.

<PAGE>   6

                  (vii) The failure of the BORROWER to pay when due any premium
                  on any policy of life or other insurance pledged hereunder, or
                  held in connection with any Collateral.

                  (viii) The LENDER deeming itself insecure as a result of an
                  impairment of the BORROWER'S ability to be reimbursed for home
                  health care services provided or to deliver home health care
                  services such that the LENDER in good faith believes that the
                  prospect of payment or performance within terms deemed
                  acceptable to the LENDER is impaired.

                  (ix) The failure of the BORROWER to either furnish the LENDER
                  within thirty (30) days after written request by the LENDER,
                  current financial statements, including income tax returns, in
                  form satisfactory to the LENDER or to permit inspection of any
                  of the BORROWER'S books or records.

                  (x) Any representation, warranty, statement, report, or
                  application made, or furnished, by the BORROWER proving to
                  have been false, erroneous or misleading, in any material
                  respect at the time of the making thereof.

                  (xi) The issuance of any tax levy or lien against the BORROWER
                  or the BORROWER'S failure to pay, withhold, collect, or remit
                  any tax when assessed or due.

                  (xii) The sale or transfer of Collateral out of the BORROWER'S
                  ordinary course of business without the LENDER'S prior written
                  consent.

                  (xiii) A bulk sale of the BORROWER'S assets.

                  (xiv) The suspension or liquidation of the BORROWER'S
                  business.

                  (xv) The existence of a consolidated net loss for any quarter,
                  other than the quarter ending December 31, 2000, during the
                  Initial Loan Amount Term and/or the Supplemental Loan Amount
                  Term.

                  (xvi) Failure by the BORROWER to fulfill all conditions
                  precedent referenced in Section 12 above on or before January
                  31, 2001; provided that, the LENDER loans the Initial Loan
                  Amount to the BORROWER prior to the delivery and/or completion
                  of the conditions precedent referenced in Section 12 above.

<PAGE>   7

         (b)      In the event of a default hereunder, any unpaid balance shall
                  bear interest at the rate of FIFTEEN PERCENT (15%) or at the
                  same rate as applicable to the principal sum, whichever is
                  higher, per annum from the time of default, transfer or
                  expiration, until this Note has been paid in full.

         (c)      In the event of a default hereunder or under any other
                  agreement between the BORROWER and/or any of its affiliates
                  and the LENDER and/or any of its affiliates, the BORROWER
                  shall be prohibited from acquiring all or part of the assets
                  or stock of another entity.

20.      REMEDIES. The LENDER shall have the following remedies:

         (a) Upon the occurrence of an Event of Default hereunder and at the
         option of the LENDER and without notice, the entire unpaid balance
         shall become immediately due and payable and the LENDER may exercise
         such additional remedies as are set forth in the Loan Agreement.

         (b) When any Obligation becomes due, whether by acceleration or
         otherwise, and at any time thereafter, the LENDER shall have all of the
         remedies provided in the security documents including the remedies or a
         secured party under the Uniform Commercial Code. Unless the Collateral
         is perishable or threatens to decline speedily in value or is of a type
         customarily sold on a recognized market, the LENDER will give the
         BORROWER reasonable notice of the time and place of any public sale
         therefor or of the time after which any private sale or other intended
         disposition is to be made. The requirement of reasonable notice shall
         be met if such notice is mailed, postage prepaid, to the last known
         address of the BORROWER at least ten (10) days before the time of the
         sale or disposition.

         (c) When any Obligation becomes due, whether by acceleration or
         otherwise, and at any time thereafter, the LENDER is empowered to
         collect, sell, assign, transfer, set over and deliver the whole or any
         part of any Collateral through any stock exchange, broker or agent or
         at any public or private sale, either for cash or credit or for future
         delivery, without assumption of credit risk, and at any such sale the
         LENDER may become the purchaser of any part of the Collateral
         discharged from right of redemption. Upon any such sale, after
         deducting all costs and expenses of every kind related to retaking,
         storing and selling the Collateral, the residue of the proceeds thereof
         may be applied as the LENDER may determine toward the payment of any or
         all of the storing and selling the Collateral, the residue of the
         proceeds thereof may be applied as the LENDER may determine toward the
         payment of any or all of the Obligations, whether due or not, returning
         the overage, if any, to the BORROWER and the BORROWER shall be and
         remain liable to the LENDER for every and any deficiency after
         application of such proceeds.

         (d) Right is expressly granted to the LENDER at its option to transfer
         at any time to itself or to its nominee any securities pledged
         hereunder, to receive and retain the income thereon, all splits,
         substitutions and divisions, and hold the same as security herefore, or

<PAGE>   8

         apply it on the principal or interest which has become due on any
         Obligation, whether by acceleration or otherwise, and, in the case of
         voting shares or interests pledged to vote the same when the LENDER
         deems the exercise of such power necessary to maintain or protect such
         Collateral.

         (e) When any such Obligation becomes due, whether by acceleration or
         otherwise, and at an time thereafter, the LENDER may, at its option,
         demand, sue for, collect, or make any compromise or settlement it deems
         desirable with reference to the Collateral. The LENDER shall not be
         bound to take any steps necessary to preserve any rights in the
         Collateral against prior parties, inasmuch as the BORROWER agrees to
         assume such responsibility. The LENDER shall have no duty with respect
         to collection or protection of the Collateral or of any income on the
         Collateral as to the preservation of any rights pertaining to the
         Collateral beyond safe custody.

         (f) When any Obligation becomes due, by acceleration or otherwise, the
         LENDER shall have the right, without notice to the BORROWER, any party
         claiming under the BORROWER, or any other party, such notice being
         hereby expressly waived, and without regard to the adequacy of value of
         the Collateral or the solvency or insolvency of the BORROWER to the
         appointment of a receiver by a court of competent jurisdiction chosen
         solely by the LENDER, upon application at any time, whether prior to or
         after a judgment has been obtained against the BORROWER, to take
         possession of the assets and/or business of the BORROWER together with
         its books and records, to maintain or to liquidate said assets and/or
         business, to collect the proceeds of the Collateral and apply the net
         proceeds to any Obligation. The BORROWER consents to jurisdiction and
         venue for the appointment of such receiver by such court and agrees
         that any receiver so appointed may take possession of the assets and/or
         business of the BORROWER, together with the Collateral in any other
         jurisdiction in which the Collateral may be located.

21. WAIVER; DELAYS OR OMISSIONS. The BORROWER waives presentment, notice,
protest, right to assert any statute of limitations and all other demands and
notices in connection with the delivery, acceptance, performance, default or
enforcement of this Note; and assents to any extension or postponement of the
time of payment, modification or waiver of any payment amount or any other
indulgence, and/or to the addition or release of any other party or person
liable hereon or of any Collateral herefor. No delay or omission on the part of
the LENDER in exercising any right hereunder shall operate as a waiver of such
right or of any other right under this Note. A waiver on any one occasion shall
not be construed as a bar to or waiver of any such right and or remedy on any
future occasion. The BORROWER agrees that the LENDER may take possession of any
Collateral without prior judicial hearing or process, hereby expressly waives
any right to such judicial hearing process, and hereby assents to any
substitution, exchange or release of Collateral.

22. AUTHORIZATION. The BORROWER authorizes the LENDER to exchange the LENDER'S
deposit, credit and borrowing information about the BORROWER with third parties.

<PAGE>   9

23. NOTICES. All notices, requests, demands and other communications to the
BORROWER under this Note shall be in writing and shall be deemed to have been
duly given on the date of service if served personally on the BORROWER
(including without limitation service by overnight courier service), or on the
third day after mailing if mailed to the BORROWER, by first class mail,
registered or certified, postage prepaid, at the address set forth below, or on
the date of service if delivered by facsimile to the facsimile number set forth
below which facsimile is confirmed within three days by deposit of a copy of
such notice in first class mail, registered or certified, postage prepaid at the
address set forth below. The BORROWER may change its address for purposes of
this paragraph by giving the LENDER written notice of the new address in the
manner set forth above.

24. BINDING EFFECT; ASSIGNABILITY. This Note shall be binding upon and inure to
the benefit of the parties hereto and their respective successors and permitted
assigns. The BORROWER may not assign any of its rights and Obligations hereunder
or any interest herein without the prior written consent of the LENDER. The
LENDER may, at any time, without the consent of the BORROWER, assign any of its
rights and Obligations hereunder or interests herein to any affiliate of the
LENDER.

25. SEVERABILITY. Each section, part, term and/or provision of this Note shall
be considered severable, and if for any reason any section, part, term and/or
provision herein is determined to be invalid and contrary to, or in conflict
with, any existing or future law or regulation, such shall not impair the
operation of or affect the remaining portions, sections, parts, terms and/or
provisions of this Note, and the latter will continue to be given full force and
effect and bind the parties hereto; and said invalid sections, parts, terms,
and/or provisions shall be deemed not part of this Note.

26. CAPTIONS. Any captions and headings herein are intended solely for the
convenience of the parties, and none shall be deemed to affect the meaning or
construction of any provision hereof.

27. WARRANT OF ATTORNEY. BORROWER jointly and severally authorizes any attorney
at law to appear in an action on this Note at any time after the same becomes
due, whether by acceleration or otherwise, in any court of record in or of the
state of Ohio, or of elsewhere, and to waive the issuing and service of process
against any or all of said parties, enter an appearance and to confess judgment
in favor of the LENDER against any or all of said parties for the amount that
may be due, together with costs of suit, and to release all errors and waive all
rights of appeal and stay of execution from the judgment rendered. After the
judgment is entered against one or more of said parties, the powers herein
conferred may be exercised as to one or more of the others.

28. GOVERNING LAW. THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE INTERNAL LAWS (AS OPPOSED TO CONFLICT OF LAWS PROVISIONS) OF THE STATE
OF OHIO. THE BORROWER HEREBY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE COURTS
OF THE STATE OF OHIO AND THE UNITED STATES DISTRICT COURT LOCATED IN THE
SOUTHERN DISTRICT OF OHIO, AND WAIVES PERSONAL SERVICE OF ANY AND

<PAGE>   10

ALL PROCESS UPON IT AND CONSENTS THAT ALL SUCH SERVICE OF PROCESS BE MADE BY
CERTIFIED MAIL AND SERVICE SO MADE SHALL BE DEEMED TO BE COMPLETED FIVE (5)
BUSINESS DAYS AFTER THE SAME SHALL HAVE BEEN DEPOSITED IN THE U.S. MAILS,
POSTAGE PREPAID. THE BORROWER HEREBY WAIVES ANY OBJECTION BASED ON FORUM NON
CONVENIENS, AND ANY OBJECTION TO VENUE OF ANY ACTION INSTITUTED HEREUNDER AND
CONSENTS TO THE GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED
APPROPRIATE BY THE COURT. NOTHING IN THIS SECTION SHALL AFFECT THE RIGHT OF THE
LENDER TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR AFFECT THE
RIGHT OF THE LENDER TO BRING ANY ACTION OR PROCEEDING AGAINST THE BORROWER OR
ITS PROPERTY IN THE COURTS OF ANY OTHER JURISDICTION. THE BORROWER HEREBY AGREES
THAT THE EXCLUSIVE AND APPROPRIATE FORUMS FOR ANY DISPUTE HEREUNDER ARE THE
COURTS OF THE STATE OF OHIO AND THE UNITED STATES DISTRICT COURT LOCATED IN THE
SOUTHERN DISTRICT OF OHIO AND AGREES NOT TO INSTITUTE ANY ACTION IN ANY OTHER
FORUM. THE BORROWER HEREBY WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN
RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE ARISING
OUT OF, CONNECTED WITH, RELATED TO, OR IN CONNECTION WITH THIS NOTE. INSTEAD,
ANY DISPUTE RESOLVED IN COURT WILL BE RESOLVED IN A BENCH TRIAL WITHOUT A JURY.

29. CONFESS JUDGMENT. After the Obligation evidenced hereby, or any part
thereof, becomes due and is unpaid, to the extent and as permitted by applicable
law, the BORROWER authorizes and empowers the Clerk of Court or any attorney at
law to appear and enter a judgment by confession or in an amicable action in any
court of competent jurisdiction under this provision in favor of the LENDER or
its assignee, with or without averment or declaration filed, for possession of
the Collateral and/or for such sum or sums as may be payable by reasons of the
terms of this Note, including any sums as may be past due at the time of
repossession or acceleration, and such additional sums as may be incurred by
reasons of the repossession of said Collateral, or become due by reason of
acceleration upon default in payment by the BORROWER, together with any and all
costs of suit, collection and reasonable attorney's fees in any court of record
in any county in the state of Ohio, or elsewhere, where the BORROWER resides,
signed this Note or can be found, and waive the issuance of service of process
and confess judgment against the undersigned in favor of the holder of this Note
for the amount then appearing due together with the costs of suit, and thereupon
to release all errors and waive all right of appeal and stay of execution. The
authority to confess judgment either for possession of the Collateral or any
money due hereunder shall not be exhausted by one exercise, but judgments may be
confessed from time to time, as often as may be necessary.

This Note was executed in Franklin County, Ohio.

             [INTENTIONALLY LEFT BLANK. SIGNATURE PAGES TO FOLLOW.]

<PAGE>   11

WARNING: BY SIGNING THIS PAPER YOU GIVE UP YOUR RIGHT TO NOTICE AND COURT TRIAL.
IF YOU DO NOT PAY ON TIME A COURT JUDGMENT MAY BE TAKEN AGAINST YOU WITHOUT YOUR
PRIOR KNOWLEDGE AND THE POWERS OF A COURT CAN BE USED TO COLLECT FROM YOU
REGARDLESS OF ANY CLAIMS YOU MAY HAVE AGAINST THE CREDITOR WHETHER FOR RETURNED
GOODS, FAULTY GOODS, FAILURE ON ITS PART TO COMPLY WITH THE AGREEMENT, OR ANY
OTHER CAUSE. (SEC. 2323.13 O.R.C.)

BORROWER:
AMEDISYS, INC.

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:   SVP

AMEDISYS ALTERNATE-SITE INFUSION
THERAPY SERVICES, INC.

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:   SVP

AMEDISYS HOME HEALTH, INC. OF ALABAMA

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:   SVP

AMEDISYS HOME HEALTH, INC. OF GEORGIA

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:   SVP

<PAGE>   12

WARNING: BY SIGNING THIS PAPER YOU GIVE UP YOUR RIGHT TO NOTICE AND COURT TRIAL.
IF YOU DO NOT PAY ON TIME A COURT JUDGMENT MAY BE TAKEN AGAINST YOU WITHOUT YOUR
PRIOR KNOWLEDGE AND THE POWERS OF A COURT CAN BE USED TO COLLECT FROM YOU
REGARDLESS OF ANY CLAIMS YOU MAY HAVE AGAINST THE CREDITOR WHETHER FOR RETURNED
GOODS, FAULTY GOODS, FAILURE ON ITS PART TO COMPLY WITH THE AGREEMENT, OR ANY
OTHER CAUSE. (SEC. 2323.13 O.R.C.)

AMEDISYS HOME HEALTH, INC. OF LOUISIANA

By: /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

AMEDISYS HOME HEALTH, INC. OF NORTH CAROLINA

By: /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

AMEDISYS HOME HEALTH, INC. OF OKLAHOMA

By: /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

AMEDISYS HOME HEALTH, INC. OF TENNESSEE

By: /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

<PAGE>   13
WARNING: BY SIGNING THIS PAPER YOU GIVE UP YOUR RIGHT TO NOTICE AND COURT TRIAL.
IF YOU DO NOT PAY ON TIME A COURT JUDGMENT MAY BE TAKEN AGAINST YOU WITHOUT YOUR
PRIOR KNOWLEDGE AND THE POWERS OF A COURT CAN BE USED TO COLLECT FROM YOU
REGARDLESS OF ANY CLAIMS YOU MAY HAVE AGAINST THE CREDITOR WHETHER FOR RETURNED
GOODS, FAULTY GOODS, FAILURE ON ITS PART TO COMPLY WITH THE AGREEMENT, OR ANY
OTHER CAUSE. (SEC. 2323.13 O.R.C.)

AMEDISYS SPECIALIZED MEDICAL SERVICES, INC.

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

HOME HEALTH OF ALEXANDRIA, INC.

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

INFUSIONCARE SOLUTIONS, INC.

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

PRN, INC.

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

<PAGE>   14

WARNING: BY SIGNING THIS PAPER YOU GIVE UP YOUR RIGHT TO NOTICE AND COURT TRIAL.
IF YOU DO NOT PAY ON TIME A COURT JUDGMENT MAY BE TAKEN AGAINST YOU WITHOUT YOUR
PRIOR KNOWLEDGE AND THE POWERS OF A COURT CAN BE USED TO COLLECT FROM YOU
REGARDLESS OF ANY CLAIMS YOU MAY HAVE AGAINST THE CREDITOR WHETHER FOR RETURNED
GOODS, FAULTY GOODS, FAILURE ON ITS PART TO COMPLY WITH THE AGREEMENT, OR ANY
OTHER CAUSE. (SEC. 2323.13 O.R.C.)

QUALITY HOME HEALTH CARE, INC.

By: /s/ JOHN M. JOFFRION
   ------------------------------------
Name:    John M. Joffrion
Title:   Senior Vice President, Finance

AMEDISYS SURGERY CENTER, L.C.

By: /s/ JOHN M. JOFFRION
   ------------------------------------
Name:    John M. Joffrion
Title:   Senior Vice President, Finance

AMEDISYS HOME HEALTH, INC. OF VIRGINIA

By: /s/ JOHN M. JOFFRION
   ------------------------------------
Name:    John M. Joffrion
Title:   Senior Vice President, Finance

AMEDISYS NORTHWEST HOME HEALTH, INC.

By: /s/ JOHN M. JOFFRION
   ------------------------------------
Name:    John M. Joffrion
Title:   Senior Vice President, Finance

<PAGE>   15

WARNING: BY SIGNING THIS PAPER YOU GIVE UP YOUR RIGHT TO NOTICE AND COURT TRIAL.
IF YOU DO NOT PAY ON TIME A COURT JUDGMENT MAY BE TAKEN AGAINST YOU WITHOUT YOUR
PRIOR KNOWLEDGE AND THE POWERS OF A COURT CAN BE USED TO COLLECT FROM YOU
REGARDLESS OF ANY CLAIMS YOU MAY HAVE AGAINST THE CREDITOR WHETHER FOR RETURNED
GOODS, FAULTY GOODS, FAILURE ON ITS PART TO COMPLY WITH THE AGREEMENT, OR ANY
OTHER CAUSE. (SEC. 2323.13 O.R.C.)

AMEDISYS HOME HEALTH, INC. OF FLORIDA

By:  /s/ JOHN M. JOFFRION
   --------------------------------
Name:    John M. Joffrion
Title:

<PAGE>   16

                                                                     SCHEDULE 1

                                   AFFILIATES

<TABLE>
<CAPTION>
                                                                         STATE OF        MAY BE REFERRED
                   NAME OF AFFILIATES                                  INCORPORATION       TO HEREIN AS
--- --------------------------------------------------------------- ------------------ ------------------
<S> <C>                                                             <C>                <C>
1.  Amedisys Home Health, Inc. of Alabama                                 Alabama          "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
2.  Amedisys Home Health, Inc. of Georgia                                 Georgia          "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
3.  Amedisys Home Health, Inc. of Louisiana                              Louisiana         "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
4.  Amedisys Home Health, Inc. of North Carolina                      North Carolina       "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
5.  Amedisys Home Health, Inc. of Oklahoma                               Oklahoma          "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
6.  Amedisys Home Health, Inc. of Tennessee                              Tennessee         "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
7.  Amedisys Specialized Medical Services, Inc.                          Louisiana         "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
8.  Home Health of Alexandria, Inc. dba Cornerstone Home Health          Louisiana         "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
9.  Quality Home Health Care, Inc.                                       Oklahoma          "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
10. Amedisys Northwest Home Health, Inc.                                  Georgia          "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
11. Amedisys Home Health, Inc. of Virginia                               Virginia          "Seller"
--- --------------------------------------------------------------- ------------------ ------------------
12. Amedisys Home Health, Inc. of Florida                                 Florida        "Non-Seller"
--- --------------------------------------------------------------- ------------------ ------------------
13. Amedisys Alternate-Site Infusion Therapy Services, Inc.              Louisiana       "Non-Seller"
--- --------------------------------------------------------------- ------------------ ------------------
14. InfusionCare Solutions, Inc. dba Precision Health                    Louisiana       "Non-Seller"
--- --------------------------------------------------------------- ------------------ ------------------
15. PRN, Inc. dba Amedisys Alternate-Site Infusion Therapy Services        Texas         "Non-Seller"
--- --------------------------------------------------------------- ------------------ ------------------
16. Amedisys Surgery Centers, L.C.                                         Texas         "Non-Seller"
--- --------------------------------------------------------------- ------------------ ------------------
</TABLE>

<PAGE>   17

                                                                      SCHEDULE 2

             OUTSTANDING ITEMS IN CONNECTION WITH THE SALE AGREEMENT

1.       Executed original UCC-3 Termination Statements, UCC-3 Partial Releases
         and/or releases of the following liens:

         o        Financing Statement Number 17-1151051 dated 6/9/98 Filed
                  in East Baton Rouge Parish, LA
                  Debtor Name and Address:
                  Amedisys Alternate-Site Infusion Therapy Services, Inc.
                  3029 S. Sherwood Forest Blvd.
                  Baton Rouge, LA  70816
                  Secured Party Name and Address:
                  Union Planters Bank, National Association
                  P. O. Box 2710
                  8440 Jefferson Hwy.
                  Baton Rouge, LA  70821

         o        Case Number DOI FI FA No. 9860119 filed 7/2/98 with the
                  Georgia Secretary of State in the amount of $3,773.33
                  Debtor Name: Coosa Valley Home Health Care Columbia
                  Homecare Coosa
                  %U C Consultants
                  233 Oceola Avenue
                  Nashville, TN 37209
                  Secured Party: Department of Labor State of Georgia
                  Unemployment Contribution EI FA

         o        Orig 998 Bundle 10796 filed 6/9/97 in the amount of $4,735.75
                  filed with the LA Dept. of State
                  Debtor Name:
                  Amedisys Home Health, Inc.
                  Secured Party Name:
                  State of LA Department of Labor Office of Employment Security

2.       Legal opinion of Seller's counsel:

         o        Louisiana legal opinion for each Seller regarding the chief
                  executive office location of each Seller;

         o        Georgia legal opinion for Amedisys Home Health, Inc. of
                  Georgia;

         o        Oklahoma legal opinion for Amedisys Home Health, Inc. of
                  Oklahoma and Quality Home Health Care, Inc.; and

         o        Tennessee legal opinion for Amedisys Home Health, Inc. of
                  Tennessee.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00019-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00019-of-00352.parquet"}]]